InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
59,578.01
(
0.58%
)

Replies to post #2867 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #2867 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DC15

02/09/24 1:36 PM

#2868 RE: vinmantoo #2867

Too bad that the challenge study results did not yield and opportunity for breakthrough therapy designation. If so then the peds and HR studies could have been powered for approval.